These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1700185)

  • 21. Rapid preoperative blockage of thyroid hormone production / secretion in patients with Graves' disease.
    Fischli S; Lucchini B; Müller W; Slahor L; Henzen C
    Swiss Med Wkly; 2016; 146():w14243. PubMed ID: 26765838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does thyroidectomy, radioactive iodine therapy, or antithyroid drug treatment alter reactivity of patients' T cells to epitopes of thyrotropin receptor in autoimmune thyroid diseases?
    Soliman M; Kaplan E; Abdel-Latif A; Scherberg N; DeGroot LJ
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2312-21. PubMed ID: 7543112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgery still has a role in Graves' hyperthyroidism.
    Patwardhan NA; Moront M; Rao S; Rossi S; Braverman LE
    Surgery; 1993 Dec; 114(6):1108-12; discussion 1112-3. PubMed ID: 8256215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A patient-specific treatment model for Graves' hyperthyroidism.
    Pandiyan B; Merrill SJ; Di Bari F; Antonelli A; Benvenga S
    Theor Biol Med Model; 2018 Jan; 15(1):1. PubMed ID: 29310665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antithyroid drug treatment for Graves' disease: baseline predictive models of relapse after treatment for a patient-tailored management.
    Masiello E; Veronesi G; Gallo D; Premoli P; Bianconi E; Rosetti S; Cusini C; Sabatino J; Ippolito S; Piantanida E; Tanda ML; Chiovato L; Wiersinga WM; Bartalena L
    J Endocrinol Invest; 2018 Dec; 41(12):1425-1432. PubMed ID: 29946800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
    Chung YJ; Lee BW; Kim JY; Jung JH; Min YK; Lee MS; Lee MK; Kim KW; Chung JH
    Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired health-related quality of life in Graves' disease. A prospective study.
    Elberling TV; Rasmussen AK; Feldt-Rasmussen U; Hørding M; Perrild H; Waldemar G
    Eur J Endocrinol; 2004 Nov; 151(5):549-55. PubMed ID: 15538931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reassessment of antithyroid drug therapy of Graves' disease.
    Feldt-Rasmussen U; Glinoer D; Orgiazzi J
    Annu Rev Med; 1993; 44():323-34. PubMed ID: 7682804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Affective symptoms and cognitive functions in the acute phase of Graves' thyrotoxicosis.
    Vogel A; Elberling TV; Hørding M; Dock J; Rasmussen AK; Feldt-Rasmussen U; Perrild H; Waldemar G
    Psychoneuroendocrinology; 2007 Jan; 32(1):36-43. PubMed ID: 17097812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronology of Graves' ophthalmopathy in an incidence cohort.
    Bartley GB; Fatourechi V; Kadrmas EF; Jacobsen SJ; Ilstrup DM; Garrity JA; Gorman CA
    Am J Ophthalmol; 1996 Apr; 121(4):426-34. PubMed ID: 8604736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Change of surgical strategy for Graves' disease from subtotal thyroidectomy to total thyroidectomy: a single institutional experience.
    Sugino K; Nagahama M; Kitagawa W; Ohkuwa K; Uruno T; Matsuzu K; Suzuki A; Tomoda C; Y Hames K; Akaishi J; Masaki C; Ogimi Y; Yabuta T; Ito K
    Endocr J; 2019 Feb; 66(2):181-186. PubMed ID: 30568070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Total thyroidectomy (Tx) versus thionamides (antithyroid drugs) in patients with moderate-to-severe Graves' ophthalmopathy - a 1-year follow-up: study protocol for a randomized controlled trial.
    Brammen L; Riss P; Lukas J; Gessl A; Dunkler D; Li S; Leisser A; Rezar-Dreindl S; Eibenberger K; Selberherr A; Scheuba C; Papp A
    Trials; 2018 Sep; 19(1):495. PubMed ID: 30219088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Remission of Graves' hyperthyroidism and A/G polymorphism at position 49 in exon 1 of cytotoxic T lymphocyte-associated molecule-4 gene.
    Kinjo Y; Takasu N; Komiya I; Tomoyose T; Takara M; Kouki T; Shimajiri Y; Yabiku K; Yoshimura H
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2593-6. PubMed ID: 12050220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A retrospective cohort study: do patients with graves' disease need to be euthyroid prior to surgery?
    Al Jassim A; Wallace T; Bouhabel S; Majdan A; Hier M; Forest VI; Payne R
    J Otolaryngol Head Neck Surg; 2018 May; 47(1):37. PubMed ID: 29784035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subtotal thyroidectomy: a reliable method to achieve euthyroidism in Graves' disease. Prognostic factors.
    Moreno P; Gómez JM; Gómez N; Francos JM; Ramos E; Rafecas A; Jaurrieta E
    World J Surg; 2006 Nov; 30(11):1950-6. PubMed ID: 17006611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Graves' disease in a mediastinal mass presenting after total thyroidectomy for nontoxic multinodular goiter: a case report.
    Cunha FM; Rodrigues E; Oliveira J; Saavedra A; Vinhas LS; Carvalho D
    J Med Case Rep; 2016 Mar; 10():70. PubMed ID: 27029843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The dilemma of how to manage Graves' hyperthyroidism in patients with associated orbitopathy.
    Bartalena L
    J Clin Endocrinol Metab; 2011 Mar; 96(3):592-9. PubMed ID: 21190983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methimazole therapy in Graves' disease influences the abnormal expression of CD69 (early activation antigen) on T cells.
    Corrales JJ; López A; Ciudad J; Mories MT; Miralles JM; Orfao A
    J Endocrinol; 1997 Dec; 155(3):491-500. PubMed ID: 9487994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Thyrotoxic crisis in a patient with Graves' disease].
    Pruijm MT; Pereira AM
    Ned Tijdschr Geneeskd; 2004 Aug; 148(34):1691-4. PubMed ID: 15453122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Remission of Graves' disease is not related to early restoration of euthyroidism with high-dose methimazole therapy.
    Kruljac I; Solter D; Vrkljan AM; Solter M
    Endocr Res; 2015; 40(1):25-8. PubMed ID: 24833206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.